COVID-19: breaking down a global health crisis

SI Mallah, OK Ghorab, S Al-Salmi, OS Abdellatif… - Annals of clinical …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

B Bikdeli, MV Madhavan, D Jimenez, T Chuich… - Journal of the American …, 2020 - jacc.org
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

[HTML][HTML] Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial

EJ Lenze, C Mattar, CF Zorumski, A Stevens… - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) may lead to serious illness as a result of
an excessive immune response. Fluvoxamine may prevent clinical deterioration by …

Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study

C Basso, O Leone, S Rizzo, M De Gaspari… - European heart …, 2020 - academic.oup.com
Abstract Aims Coronavirus disease 2019 (COVID-19) due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has been associated with cardiovascular features of …

[PDF][PDF] Coronavirus disease 2019: Tinjauan literatur terkini

A Susilo, CM Rumende, CW Pitoyo… - Jurnal penyakit dalam …, 2020 - 61.8.75.226
Pada awal 2020, dunia dikejutkan dengan mewabahnya pneumonia baru yang bermula
dari Wuhan, Provinsi Hubei yang kemudian menyebar dengan cepat ke lebih dari 190 …

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

J Phua, L Weng, L Ling, M Egi, CM Lim… - The lancet respiratory …, 2020 - thelancet.com
Summary As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive
care unit (ICU) community must prepare for the challenges associated with this pandemic …

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

TJ Guzik, SA Mohiddin, A Dimarco, V Patel… - Cardiovascular …, 2020 - academic.oup.com
The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …

Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic

E Driggin, MV Madhavan, B Bikdeli, T Chuich… - Journal of the American …, 2020 - jacc.org
Abstract The coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 that has significant implications for the …

The science underlying COVID-19: implications for the cardiovascular system

PP Liu, A Blet, D Smyth, H Li - Circulation, 2020 - Am Heart Assoc
The coronavirus disease 2019 (COVID-19) pandemic has affected health and economy
worldwide on an unprecedented scale. Patients have diverse clinical outcomes, but those …

Predictors of mortality in hospitalized COVID‐19 patients: a systematic review and meta‐analysis

W Tian, W Jiang, J Yao, CJ Nicholson… - Journal of medical …, 2020 - Wiley Online Library
Mortality rates of coronavirus disease‐2019 (COVID‐19) continue to rise across the world.
Information regarding the predictors of mortality in patients with COVID‐19 remains scarce …